OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
PEGylated mechano growth factor. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low reported | 200 mcg | 2× weekly | 0.15 mL | 15 u | 10 doses | |
| Standard | 300 mcg | 2× weekly | 0.225 mL | 22.5 u | 6 doses | |
| Upper reported | 400 mcg | 2–3× weekly | 0.3 mL | 30 u | 5 doses |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 200 mcg | twice weekly | 0.15 mL | 15 u | 4 | 0.8 mg |
| Weeks 3–4 | 300 mcg | twice weekly | 0.225 mL | 22.5 u | 4 | 1.2 mg |
| Week 5 onward per 4 weeks from here on |
400 mcg | 2.5× weekly | 0.3 mL | 30 u | 10 | 4 mg |
MGF with polyethylene glycol conjugation to extend circulating half-life from minutes to days. Entirely preclinical and community-derived dosing.
Buy PEG-MGFthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
A splice variant of IGF-1 expressed in muscle after mechanical loading, implicated in satellite cell activation. Extremely short-l…
A synthetic tetrapeptide from the Khavinson bioregulator programme, associated with telomerase activation and pineal regulation cl…
Every compound compared in one table: dose range, how often, half-life and evidence tier.